Streetbeat News

Products Services

SYK

Stryker has announced a definitive agreement to acquire Vertos Medical, a company specializing in minimally invasive treatments for lumbar spinal stenosis. This acquisition aligns with Stryker's focus on innovative medical technologies.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:01 pm

NVDA

The article compares the risk-adjusted returns of Bitcoin and Nvidia. Bitcoin has risen 43% year-to-date but has a negative Sharpe ratio, indicating lower risk-adjusted returns. Nvidia, on the other hand, has surged 166% with a Sharpe ratio of 2.29, suggesting better risk-adjusted performance.

Portfolio Pulse from Aniket Verma

August 22, 2024 | 11:45 am

CGTX

Cognition Therapeutics announced the publication of results from the SEQUEL study of CT1812, their lead candidate for Alzheimer's disease, in the Journal of Prevention of Alzheimer's Disease.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:43 am

AAP

CG

Advance Auto Parts (AAP) reported disappointing Q2 earnings, missing EPS expectations and lowering its FY24 outlook. The company announced the sale of its Worldpac business to The Carlyle Group (CG) for $1.5 billion. AAP shares fell 11.2% in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

August 22, 2024 | 11:42 am

LLY

Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly to use AbiProt technology for generating antibodies targeting high-value targets.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:42 am

PTN

Palatin Technologies has initiated patient dosing in a Phase 2 study of Bremelanotide co-administered with Tirzepatide for obesity. Enrollment is expected to complete in Q3 2024, with topline data anticipated in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:34 am

NXST

Nexstar Media Group, Inc. announced that five of its television stations will become affiliates of The CW Network, starting in September and October. This move will allow these stations to carry CW's primetime entertainment, live sports, and special event programming.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:20 am

MRK

Health Canada has approved Merck's Keytruda in combination with Enfortumab Vedotin for treating adult patients with unresectable locally advanced or metastatic urothelial cancer who have not received prior systemic therapy.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:10 am

SKYE

Skye Bioscience has initiated patient screening for a Phase 2 trial of Nimacimab, a weight loss therapeutic for obese patients. Interim data is expected in Q2 2025, with final results in Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:06 am

VERI

Veritone has announced a strategic partnership with Nuix to enhance the NEO platform and ecosystem, optimizing audio and visual workflows. This collaboration integrates Veritone's aiWARE™ with Nuix's platform to provide comprehensive solutions for handling various media files and ensuring data privacy.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:02 am